Differential diagnosis of suspected multiple sclerosis: global health considerations
Issued Date
2024-10-01
Resource Type
ISSN
14744422
eISSN
14744465
Scopus ID
2-s2.0-85204025171
Journal Title
The Lancet Neurology
Volume
23
Issue
10
Start Page
1035
End Page
1049
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet Neurology Vol.23 No.10 (2024) , 1035-1049
Suggested Citation
Correale J., Solomon A.J., Cohen J.A., Banwell B.L., Gracia F., Gyang T.V., de Bedoya F.H.D., Harnegie M.P., Hemmer B., Jacob A., Kim H.J., Marrie R.A., Mateen F.J., Newsome S.D., Pandit L., Prayoonwiwat N., Sahraian M.A., Sato D.K., Saylor D., Shi F.D., Siva A., Tan K., Viswanathan S., Wattjes M.P., Weinshenker B., Yamout B., Fujihara K. Differential diagnosis of suspected multiple sclerosis: global health considerations. The Lancet Neurology Vol.23 No.10 (2024) , 1035-1049. 1049. doi:10.1016/S1474-4422(24)00256-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/101311
Title
Differential diagnosis of suspected multiple sclerosis: global health considerations
Author(s)
Correale J.
Solomon A.J.
Cohen J.A.
Banwell B.L.
Gracia F.
Gyang T.V.
de Bedoya F.H.D.
Harnegie M.P.
Hemmer B.
Jacob A.
Kim H.J.
Marrie R.A.
Mateen F.J.
Newsome S.D.
Pandit L.
Prayoonwiwat N.
Sahraian M.A.
Sato D.K.
Saylor D.
Shi F.D.
Siva A.
Tan K.
Viswanathan S.
Wattjes M.P.
Weinshenker B.
Yamout B.
Fujihara K.
Solomon A.J.
Cohen J.A.
Banwell B.L.
Gracia F.
Gyang T.V.
de Bedoya F.H.D.
Harnegie M.P.
Hemmer B.
Jacob A.
Kim H.J.
Marrie R.A.
Mateen F.J.
Newsome S.D.
Pandit L.
Prayoonwiwat N.
Sahraian M.A.
Sato D.K.
Saylor D.
Shi F.D.
Siva A.
Tan K.
Viswanathan S.
Wattjes M.P.
Weinshenker B.
Yamout B.
Fujihara K.
Author's Affiliation
Universidad Interamericana de Panamá
Siriraj Hospital
Multiple Sclerosis Research Center
Cleveland Clinic Abu Dhabi
Klinikum Rechts der Isar
Duke-NUS Medical School
Beijing Tiantan Hospital, Capital Medical University
University Teaching Hospital Lusaka
Universidad Nacional de Asuncion
K.S. Hegde Medical Academy
National Cancer Center, Gyeonggi
University of Vermont Larner College of Medicine
University of Virginia School of Medicine
Freie Universität Berlin
The Children's Hospital of Philadelphia
Kuala Lumpur Hospital
National Neuroscience Institute of Singapore
Fundacion Para La Lucha Contra Las Enfermedades Neurologicas de La Infancia
Cleveland Clinic Foundation
Pontifícia Universidade Católica do Rio Grande do Sul
Tianjin Medical University
Max Rady College of Medicine, University of Manitoba
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine
Harvard University
The Ohio State University
Fukushima Medical University
Universidad de Buenos Aires
Johns Hopkins University School of Medicine
Harley Street Medical Center
Siriraj Hospital
Multiple Sclerosis Research Center
Cleveland Clinic Abu Dhabi
Klinikum Rechts der Isar
Duke-NUS Medical School
Beijing Tiantan Hospital, Capital Medical University
University Teaching Hospital Lusaka
Universidad Nacional de Asuncion
K.S. Hegde Medical Academy
National Cancer Center, Gyeonggi
University of Vermont Larner College of Medicine
University of Virginia School of Medicine
Freie Universität Berlin
The Children's Hospital of Philadelphia
Kuala Lumpur Hospital
National Neuroscience Institute of Singapore
Fundacion Para La Lucha Contra Las Enfermedades Neurologicas de La Infancia
Cleveland Clinic Foundation
Pontifícia Universidade Católica do Rio Grande do Sul
Tianjin Medical University
Max Rady College of Medicine, University of Manitoba
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine
Harvard University
The Ohio State University
Fukushima Medical University
Universidad de Buenos Aires
Johns Hopkins University School of Medicine
Harley Street Medical Center
Corresponding Author(s)
Other Contributor(s)
Abstract
The differential diagnosis of multiple sclerosis can present specific challenges in patients from Latin America, Africa, the Middle East, eastern Europe, southeast Asia, and the Western Pacific. In these areas, environmental factors, genetic background, and access to medical care can differ substantially from those in North America and western Europe, where multiple sclerosis is most common. Furthermore, multiple sclerosis diagnostic criteria have been developed primarily using data from North America and western Europe. Although some diagnoses mistaken for multiple sclerosis are common regardless of location, a comprehensive approach to the differential diagnosis of multiple sclerosis in Latin America, Africa, the Middle East, eastern Europe, southeast Asia, and the Western Pacific regions requires special consideration of diseases that are prevalent in those locations. A collaborative effort has therefore assessed global differences in multiple sclerosis differential diagnoses and proposed recommendations for evaluating patients with suspected multiple sclerosis in regions beyond North America and western Europe.